In addition, GLP1 intervention significantly improved overall cholesterol metabolism and reduced fasting hypercholesterolemia in DIO mice, when compared to the non-incretin-secreting isogenic control. This evidence concerns the gene GLP1R and familial hypercholesterolemia.